A significant shift in Canadian drug policy has happened, as the regulators allow the legalization of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were heavily restricted, but a growing body of research suggests they could offer benefits for emotional illnesses like PTSD. This development represents a major step